Northstar Neuroscience Clinical & Regulatory Head Resigns
Luke Timmerman9/5/08
Northstar Neuroscience, the Seattle-based maker of a electrical brain stimulation device for depression, said today that Nawzer Mehta has resigned his job as vice president of clinical and regulatory affairs to pursue another opportunity. Mehta will be replaced by Deborah Sheffield, the company’s director of regulatory affairs. Northstar has switched its strategy to concentrate on depression after its device failed to restore arm movement for stroke patients in a large clinical trial.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
